Dechert served as legal counsel to Aquestive Therapeutics, Inc., while Cooley acted for the underwriters on the offering. Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the...
Aquestive Therapeutics’ $75 Million Common Stock Offering
Vertex’s $320 Million Acquisition of ViaCyte
Skadden advised Vertex Pharmaceuticals Incorporated on the deal while Cooley represented ViaCyte. Vertex Pharmaceuticals Incorporated (“Vertex”) has entered into a definitive agreement under which Vertex will acquire...